Correction: Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization

Correction: Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795157/?tool=EBI

Similar Items

Correction: Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization.
by: Rajesh Ringe, et al.
Published: (2013-01-01)

Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization.
by: Rajesh Ringe, et al.
Published: (2012-01-01)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2019-03-01)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
by: Labranche, CC, et al.
Published: (2018)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2018-11-01)

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
by: Yuanyuan Hu, et al.
Published: (2021-03-01)

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
by: Laurent Verkoczy, et al.
Published: (2014-05-01)

Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies.
by: Devin Sok, et al.
Published: (2013-12-01)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.
by: Nitesh Mishra, et al.
Published: (2021-09-01)

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2019-12-01)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
by: Marianne Boutin, et al.
Published: (2022-06-01)

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
by: Dai Zhang, et al.
Published: (2019-05-01)

The expanding array of HIV broadly neutralizing antibodies
by: Laura E. McCoy
Published: (2018-10-01)

Broadly Neutralizing Antibodies for HIV-1 Prevention
by: Stephen R. Walsh, et al.
Published: (2021-07-01)

Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities
by: Ranajoy Mullick, et al.
Published: (2021-05-01)

B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes
by: Sanjeev Kumar, et al.
Published: (2024-02-01)

Broadly neutralizing antibodies in HIV-1 treatment and prevention
by: Rajesh Kumar, et al.
Published: (2018-08-01)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
by: Ferguson, Andrew L., et al.
Published: (2014)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
by: Sok, Devin, et al.
Published: (2014)

Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
by: Andrew L Ferguson, et al.
Published: (2013-01-01)

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
by: LaBranche, C, et al.
Published: (2019)

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2019-09-01)

Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
by: Lucia Reh, et al.
Published: (2018-01-01)

Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa.
by: Scott A McKinley, et al.
Published: (2014-01-01)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
by: Haynes, BF, et al.
Published: (2022)

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
by: Yubin Liu, et al.
Published: (2020-01-01)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
by: Sarah Wilmschen, et al.
Published: (2019-09-01)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
by: Timothée Bruel, et al.
Published: (2016-03-01)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
by: Yvonne Rosenberg, et al.
Published: (2015-01-01)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
by: Aaby P, et al.
Published: (2009-10-01)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
by: Natasha O. Moraka, et al.
Published: (2023-10-01)

Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.
by: Ben-Jiang Ma, et al.
Published: (2011-09-01)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
by: Guo D, et al.
Published: (2012-09-01)

Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
by: Joseph G Jardine, et al.
Published: (2016-09-01)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III.
by: Dan Hu, et al.
Published: (2019-06-01)

Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies
by: Maya Contreras, et al.
Published: (2024-02-01)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody.
by: Anna Buchman, et al.
Published: (2020-04-01)